Fmoc-beta-(2-quinolyl)-D-Ala-OH is a protected, non-natural amino acid derivative featuring a D-alanine backbone bearing a beta-(2-quinolyl) substituent, classifiable as an Fmoc-protected amino acid with an aromatic heterocycle side chain. The molecule contains a free carboxylic acid (-COOH) and an Fmoc-protected alpha-amino group, with the beta-position substituted by a 2-quinolyl moiety that provides a rigid, conjugated aromatic functionality for π-interactions and hydrophobic/aromatic character. In peptide and peptidomimetic synthesis workflows, the Fmoc-protected amino group supports stepwise coupling while the quinolyl-bearing side chain functions as a structural handle for structure-activity studies, fluorescent/labeling-compatible scaffold design, or incorporation into defined amino acid sequences for chemical biology applications.
CAT No: CP26791
CAS No:214852-58-1
Synonyms/Alias:Fmoc-beta-(2-quinolyl)-d-ala-oh;214852-58-1;FMOC-BETA--D-ALA-OH;Fmoc-3-(2'-quinolyl)-D-alanine;ZINC2244305;V4359;B-7882
Fmoc-beta-(2-quinolyl)-D-Ala-OH is a D-alanine-based amino acid derivative bearing an Fmoc-protected amino group and a β-substituted 2-quinolyl side chain that introduces a fused aromatic heterocycle with defined stereochemistry at the α-carbon. The molecule contains a free carboxylic acid for coupling chemistry, while the Fmoc group provides orthogonal protection compatible with standard base-labile deprotection strategies used in peptide synthesis. The quinoline ring system contributes aromatic π-surface, basic heteroatom character, and potential for metal coordination or π-π interactions, which can influence peptide conformation and binding-site recognition. As a chiral amino acid intermediate and protected peptide building block, it can be incorporated into sequences to generate β-heteroaryl-substituted D-amino acid motifs for downstream derivatization and structure-focused synthetic studies.
1. Peptide Synthesis
Fmoc-beta-(2-quinolyl)-D-Ala-OH is used in peptide building block workflows where Fmoc protection and a free carboxyl group enable stepwise peptide coupling on solid support. The D-configuration at the α-carbon supports stereochemically defined incorporation into peptide chains, while the β-(2-quinolyl) substituent provides a rigid aromatic side chain that can modulate local backbone geometry and side-chain orientation during synthesis. The quinoline nitrogen and aromatic surface can participate in noncovalent interactions after incorporation, supporting the construction of peptide analogs for binding studies and scaffold diversification. The resulting peptide products can be further processed for purification, analytical characterization, and side-chain functional exploration consistent with amino acid chemistry and peptide science.
2. Peptidomimetics And SAR
Fmoc-beta-(2-quinolyl)-D-Ala-OH serves in peptidomimetic design and structure-activity relationship studies where introduction of a β-heteroaryl D-amino acid unit enables systematic variation of aromatic electronics and steric presentation. The Fmoc-protected amine allows controlled placement within synthetic sequences, and the β-quinoline substituent provides a recognizable pharmacophore-like element that can be tuned through sequence context rather than late-stage functionalization. The stereochemical inversion associated with D-amino acid incorporation can alter proteolytic stability and backbone preferences, supporting comparative SAR mapping across analog series. Downstream derivatives prepared from the incorporated quinoline motif can be used as defined intermediates for library synthesis, receptor-binding assays, and mechanistic investigations of structure-function relationships.
3. Chemical Biology Probes
Fmoc-beta-(2-quinolyl)-D-Ala-OH can be applied to chemical biology research as a defined aromatic heterocycle-containing amino acid building block for probe construction. The quinoline ring can act as an interaction handle for molecular recognition and may enable conjugate formation strategies that rely on aromatic stacking, heteroatom coordination, or subsequent derivatization at the heteroaryl framework. The Fmoc-protected amino functionality supports incorporation into peptide or peptoid constructs that present the probe moiety at a controlled position relative to other functional groups. The resulting labeled or functionalized biomolecule scaffolds can be used to study binding interfaces, trafficking of peptide mimetics, or structure-dependent recognition in biochemical assays.
4. Bioconjugation Chemistry
Fmoc-beta-(2-quinolyl)-D-Ala-OH is suitable for bioconjugation-oriented intermediate preparation where a protected amino acid can be incorporated into conjugatable peptides bearing defined aromatic side chains. The free carboxylic acid enables formation of activated ester or amide linkages during peptide assembly, while the Fmoc group supports orthogonal protection/deprotection so that conjugation handles can be introduced at later stages in a controlled manner. The β-quinoline substituent provides a stable heteroaryl element that can remain intact through peptide coupling steps and subsequent conjugation chemistry, supporting consistent labeling motifs across batches. Downstream conjugates prepared from quinoline-bearing peptide frameworks can function as analytical standards, affinity reagents, or molecular probes for biochemical research workflows.
5. Process Chemistry Intermediate
Fmoc-beta-(2-quinolyl)-D-Ala-OH is relevant to process chemistry intermediate preparation for manufacturing of Fmoc-protected amino acid building blocks used in peptide and peptidomimetic production. The presence of an Fmoc-protected amine and a carboxylic acid supports robust, scalable coupling and protection strategies that align with common industrial peptide synthesis logic, including base-mediated Fmoc removal and controlled amide bond formation. The heteroaryl quinoline side chain can withstand typical peptide synthesis conditions and provides a defined structural element that reduces reliance on late-stage heterocycle installation. The compound can therefore be employed as a chiral, stereochemically defined intermediate for specialty chemical production, enabling reproducible generation of β-quinoline D-amino acid motifs in downstream fine chemical and peptide manufacturing processes.
6. Analytical Research Standards
Fmoc-beta-(2-quinolyl)-D-Ala-OH is applicable to analytical research and method development as a stereochemically defined reference material for characterizing peptide derivatives containing β-(2-quinolyl) D-alanine motifs. The Fmoc group and quinoline heteroaromatic functionality provide strong spectroscopic and chromatographic signatures that can aid in LC-MS, UV detection, and MS/MS fragmentation interpretation for peptide coupling verification. The free acid and protected amine allow preparation of defined standards, calibration materials, or internal reference compounds that reflect the exact structural features of target peptide building blocks. The resulting analytical utility supports reliable monitoring of synthesis progress, impurity profiling, and structural confirmation in peptide science and applied amino acid chemistry.
2. Myotropic activity of allatostatins in tenebrionid beetles
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.